Bulletin
Investor Alert

ICU Medical Inc.

NAS: ICUI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 3, 2021, 6:03 p.m.

/zigman2/quotes/208026181/composite

$

220.96

Change

0.00 0.00%

Volume

Volume 5,075

Quotes are delayed by 20 min

/zigman2/quotes/208026181/composite

Previous close

$ 227.24

$ 220.96

Change

-6.28 -2.76%

Day low

Day high

$220.00

$228.59

Open

52 week low

52 week high

$183.39

$282.00

Open

Virginia Sanzone

Virginia Sanzone occupies the position of Secretary, Vice President & General Counsel for ICU Medical, Inc.

Ms. Sanzone previously was Senior Vice President at CareFusion Corp.

Transactions

Date Shares Transaction Value
09/10/2021 248   Disposition at $252.82 per share. 62,700
09/10/2021 401   Disposition at $251.27 per share. 100,760
09/10/2021 151   Disposition at $250.23 per share. 37,785
05/11/2021 983   Disposition at $200.11 per share. 196,709
03/06/2021 839   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2021 1,595   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2021 760   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2021 1,444   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2021 554   Derivative/Non-derivative trans. at $0 per share. 0
02/18/2021 1,005   Derivative/Non-derivative trans. at $0 per share. 0
03/27/2020 312   Derivative/Non-derivative trans. at $0 per share. 0
03/27/2020 593   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2020 759   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2020 1,443   Derivative/Non-derivative trans. at $0 per share. 0
02/14/2020 529   Derivative/Non-derivative trans. at $0 per share. 0
02/14/2020 1,006   Derivative/Non-derivative trans. at $0 per share. 0
02/03/2020 2,487   Disposition at $182.13 per share. 452,958
01/17/2020 2,847   Derivative/Non-derivative trans. at $0 per share. 0
01/17/2020 5,334   Derivative/Non-derivative trans. at $0 per share. 0
09/04/2019 3,000   Disposition at $154.08 per share. 462,240
03/27/2019 593   Derivative/Non-derivative trans. at $0 per share. 0
03/27/2019 295   Derivative/Non-derivative trans. at $0 per share. 0
03/07/2019 200   Disposition at $233.35 per share. 46,670
03/07/2019 2,980   Disposition at $232.67 per share. 693,357
03/07/2019 2,097   Disposition at $231.7 per share. 485,875
03/06/2019 5,133   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2019 10,410   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2019 348   Derivative/Non-derivative trans. at $0 per share. 0
02/15/2019 1,006   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2019 1,157   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2019 425   Derivative/Non-derivative trans. at $0 per share. 0
08/28/2018 787   Disposition at $303.12 per share. 238,556
08/24/2018 1,512   Derivative/Non-derivative trans. at $0 per share. 0
08/24/2018 3,049   Derivative/Non-derivative trans. at $0 per share. 0
05/15/2018 500   Disposition at $269.85 per share. 134,925
03/27/2018 205   Derivative/Non-derivative trans. at $0 per share. 0
03/27/2018 592   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2018 427   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2018 1,157   Derivative/Non-derivative trans. at $0 per share. 0
09/07/2017 102   Disposition at $174.54 per share. 17,804
09/07/2017 1,682   Disposition at $174.46 per share. 293,442
08/24/2017 1,265   Derivative/Non-derivative trans. at $167.95 per share. 212,457
08/24/2017 3,049   Derivative/Non-derivative trans. at $0 per share. 0
03/06/2017 681   Disposition at $148.38 per share. 101,047
02/05/2017 475   Derivative/Non-derivative trans. at $0 per share. 0
02/05/2017 1,156   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Vivek Jain
Chairman & Chief Executive Officer
Mr. Christian Voigtlander
Chief Operating Officer
Mr. Brian M. Bonnell
Chief Financial Officer & Treasurer
Mr. Krishna Uppugonduri
VP-Quality, Medical & Regulatory Affairs
Ms. Virginia Sanzone
Secretary, Vice President & General Counsel
Mr. Daniel Woolson
Vice President & General Manager-Infusion Systems
Dr. George A. Lopez
Director
Ms. Laurie Hernandez
Director
Mr. Thomas D. McCall
VP-Marketing & Communications, GM-Critical Care
Mr. Kevin J. McGrody
Chief Accounting Officer
Mr. Clay Fradd
Vice President-Human Resources
Mr. David C. Greenberg
Lead Independent Director
Ms. Elisha Wade Finney
Independent Director
Mr. Donald M. Abbey
Independent Director
Mr. David F. Hoffmeister
Independent Director
Dr. Robert S. Swinney
Independent Director
Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.